Treatment | Diabetes Textbook

New Study Highlights Potential for Early Detection of Diabetes through Household Analysis

A recent study presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Vienna, Austria, suggests that analyzing electronic health records of people living in the same household as individuals with prediabetes can help identify those at high risk of developing type 2 diabetes. The study, led by Dr. Tainayah Thomas from Stanford University, used electronic health record (EHR) and administrative data to identify household members of adult patients with prediabetes and evaluate their diabetes risk factors.

Key Findings

The study identified nearly 30,000 adults with type 2 diabetes and almost 50,000 with prediabetes living in the same households as index cases with prediabetes. The researchers found that [1]:

65% of adult household members had diabetes risk factors, including overweight or obesity, hypertension, abnormal blood fats, or cardiovascular disease.
32% of adult household members had an abnormal blood sugar profile, indicating prediabetes.
20% of adult household members had prediabetes laboratory results, and 12% had blood test results showing full-blown type 2 diabetes.

Implications for Diabetes Prevention

The study’s findings highlight the potential for early detection and prevention of diabetes by analyzing household members of individuals with prediabetes. By identifying high-risk individuals within households, healthcare providers can target prevention efforts and promote lifestyle changes to reduce the risk of developing type 2 diabetes.

Future Directions

The researchers plan to further investigate household members, including assessing follow-up care, diagnosis of diabetes or other conditions, enrollment in lifestyle interventions, and prescription of glucose-lowering medications. This study’s approach could be used by health systems to identify and tailor diabetes prevention messaging and programs to entire households instead of just individuals.

This study demonstrates the potential for using electronic health records to assess household diabetes risk and identify high-risk individuals. By targeting prevention efforts at the household level, healthcare providers may be able to reduce the incidence of type 2 diabetes and improve health outcomes for individuals and families.

The Importance of Breakfast for Individuals with Diabetes

Breakfast is a crucial meal for individuals with diabetes, as it helps to regulate blood sugar levels and provide energy for the day ahead. A well-balanced breakfast can help individuals with diabetes manage their condition and reduce the risk of complications.

Nutritional Requirements for Breakfast

Individuals with diabetes should aim to include a balance of protein, healthy fats, and complex carbohydrates in their breakfast. This can help to [1]:

Regulate blood sugar levels: Complex carbohydrates, such as whole grains, fruits, and vegetables, can help to regulate blood sugar levels and provide sustained energy.
Provide satiety: Protein and healthy fats can help to provide satiety and reduce the risk of overeating.
Support overall health: A balanced breakfast can provide essential vitamins, minerals, and antioxidants that support overall health.

Best Breakfast Foods for Diabetes

Some of the best breakfast foods for individuals with diabetes include [2]:

Oatmeal: Oatmeal is a complex carbohydrate that can help to regulate blood sugar levels and provide sustained energy.
Eggs: Eggs are a good source of protein and can help to provide satiety.
Avocado: Avocado is a healthy fat that can help to provide sustained energy and support heart health.
Berries: Berries are rich in antioxidants and fiber, and can help to regulate blood sugar levels.
Whole grain toast: Whole grain toast is a complex carbohydrate that can help to regulate blood sugar levels and provide sustained energy.

Breakfast Ideas for Diabetes

Some healthy breakfast ideas for individuals with diabetes include [3]:

Oatmeal with fruit and nuts: Cook oatmeal with milk or water and top with fruit and nuts for added fiber and protein.
Avocado toast: Toast whole grain bread and top with mashed avocado, eggs, and a sprinkle of red pepper flakes.
Greek yogurt with berries: Mix Greek yogurt with berries and a sprinkle of granola for added crunch and fiber.
Smoothie bowl: Blend together Greek yogurt, frozen berries, and spinach, then top with granola, nuts, and seeds.

Foods to Avoid at Breakfast

Some foods that individuals with diabetes may want to avoid at breakfast include [4]:

Sugary cereals: Sugary cereals can cause a spike in blood sugar levels and provide little nutritional value.
Refined grains: Refined grains, such as white bread, can cause a spike in blood sugar levels and provide little nutritional value.
Processed meats: Processed meats, such as bacon and sausage, can be high in sodium and saturated fat.

Breakfast is an important meal for individuals with diabetes, and choosing the right foods can help to regulate blood sugar levels and provide energy for the day ahead. By including a balance of protein, healthy fats, and complex carbohydrates in their breakfast, individuals with diabetes can help to manage their condition and reduce the risk of complications.

References

American Diabetes Association. (2022). Standards of Medical Care in Diabetes. Diabetes Care, 45(Supplement 1), S1-S212.
Evert AB, et al. (2019). Nutrition therapy for adults with diabetes or prediabetes: A consensus report. Diabetes Care, 42(5), 731-754.
Franz MJ, et al. (2019). Medical nutrition therapy for type 2 diabetes: An update. Diabetes Spectrum, 32(3), 249-258.
Sheard NF, et al. (2019). Dietary carbohydrate (amount and type) in the prevention and management of diabetes: A statement by the American Diabetes Association. Diabetes Care, 42(5), 755-763.

Big gains in type 1 diabetes glucose-control management in recent years

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health reveals significant improvements in blood sugar management among individuals with type 1 diabetes over the past 15 years, driven by the widespread adoption of continuous glucose monitoring (CGM) and insulin delivery devices.

The study analyzed nearly 200,000 de-identified electronic health records from 2009 to 2023, tracking the use of CGM and insulin pumps alongside blood sugar control (measured by HbA1c levels). Key findings include:

Improved Glucose Control: The percentage of children under 18 with optimal HbA1c levels (<7%) rose from 7% (2009–2011) to 19% (2021–2023)—a 171% increase. Among adults, optimal control increased from 21% to 28% (33% increase).
Surge in Technology Use:
- CGM adoption skyrocketed from 4% to 82% in youths and 5% to 57% in adults.
- Insulin pump use rose from 16% to 50% in youths and 11% to 29% in adults.
- Concurrent use of both devices jumped from 1% to 47% in youths and 1% to 22% in adults.

Despite progress, disparities persist, with non-Hispanic white patients and those with commercial insurance showing higher rates of technology adoption and glucose control. For example, only 12% of non-Hispanic Black youths achieved optimal control in 2021–2023, compared to 21% of non-Hispanic white youths.

The researchers emphasize the need for better access to diabetes technologies to reduce these gaps. While the advancements are promising, most patients still do not meet optimal glucose targets, indicating room for further improvement.

Published in JAMA Network Open (August 11), the study highlights how modern diabetes technologies have transformed care, with future research planned to examine long-term complications like heart and kidney disease in type 1 diabetes patients.

Key Takeaways:

Technology Drives Improvement: CGM and insulin pumps have significantly enhanced blood sugar management.
Disparities Remain: Racial and insurance-based gaps in access and outcomes need addressing.
Ongoing Challenges: Most patients still lack optimal control, calling for further innovation and policy changes.

DASH Diet Modified for Diabetes Lowers Blood Sugar Levels in Clinical Trial

A recent clinical trial led by researchers at Johns Hopkins Bloomberg School of Public Health found that a modified version of the DASH diet, called DASH4D, is effective in lowering blood sugar levels in adults with type 2 diabetes. The DASH4D diet is similar to the original DASH diet but is lower in carbohydrates and higher in unsaturated fats, with reduced potassium levels to improve safety for individuals with chronic kidney disease.

The study, published in Nature Medicine, involved 89 participants with type 2 diabetes who ate prepared meals at a clinical research center for 20 weeks. The results showed that when participants consumed the DASH4D diet, they had a clinically meaningful reduction in average blood glucose level and an increase in average time spent with blood glucose in the recommended range compared to when they consumed a standard diet.

Specifically, the study found that:

Participants on the DASH4D diet had blood sugar levels that were on average 11 mg/dL lower than when eating the standard diet.
Participants on the DASH4D diet stayed in the optimal blood glucose range for an extra 75 minutes a day.
Larger improvements were seen in participants who had higher blood glucose levels at the start of the trial, with those with HbA1c above 8% experiencing an increase in time in the optimal blood glucose range by about three hours per day.

The researchers hope that the results will lead to incorporating the DASH4D diet into clinical guidelines and improving type 2 diabetes management in the broader population. The study’s findings suggest that the DASH4D diet can be a sustainable and effective approach to managing type 2 diabetes, with potential benefits for population health.

Phase 3 study supports use of canagliflozin for type 2 diabetes in children and adolescents

A recent phase 3 clinical trial published in Annals of Internal Medicine supports the use of canagliflozin for treating type 2 diabetes in children and adolescents. The study involved 171 participants aged 10-18 years with inadequate glycemic control, who received either oral canagliflozin or a placebo for 52 weeks.